1. Home
  2. BIO vs CAE Comparison

BIO vs CAE Comparison

Compare BIO & CAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • CAE
  • Stock Information
  • Founded
  • BIO 1952
  • CAE 1947
  • Country
  • BIO United States
  • CAE Canada
  • Employees
  • BIO N/A
  • CAE N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • CAE
  • Sector
  • BIO Industrials
  • CAE
  • Exchange
  • BIO Nasdaq
  • CAE Nasdaq
  • Market Cap
  • BIO 6.9B
  • CAE 6.7B
  • IPO Year
  • BIO N/A
  • CAE N/A
  • Fundamental
  • Price
  • BIO $249.64
  • CAE $24.26
  • Analyst Decision
  • BIO Strong Buy
  • CAE Buy
  • Analyst Count
  • BIO 4
  • CAE 3
  • Target Price
  • BIO $396.50
  • CAE $32.00
  • AVG Volume (30 Days)
  • BIO 385.0K
  • CAE 484.0K
  • Earning Date
  • BIO 05-01-2025
  • CAE 05-27-2025
  • Dividend Yield
  • BIO N/A
  • CAE N/A
  • EPS Growth
  • BIO N/A
  • CAE N/A
  • EPS
  • BIO N/A
  • CAE N/A
  • Revenue
  • BIO $2,566,500,000.00
  • CAE $3,168,385,644.00
  • Revenue This Year
  • BIO $0.88
  • CAE $11.56
  • Revenue Next Year
  • BIO $4.44
  • CAE $6.97
  • P/E Ratio
  • BIO N/A
  • CAE N/A
  • Revenue Growth
  • BIO N/A
  • CAE 4.71
  • 52 Week Low
  • BIO $215.38
  • CAE $15.95
  • 52 Week High
  • BIO $387.99
  • CAE $27.62
  • Technical
  • Relative Strength Index (RSI)
  • BIO 49.87
  • CAE 54.00
  • Support Level
  • BIO $232.53
  • CAE $22.96
  • Resistance Level
  • BIO $260.00
  • CAE $24.32
  • Average True Range (ATR)
  • BIO 12.19
  • CAE 0.82
  • MACD
  • BIO 2.60
  • CAE 0.17
  • Stochastic Oscillator
  • BIO 71.26
  • CAE 93.56

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a global training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

Share on Social Networks: